Inhibition of insulin secretion by interleukin‐1β and tumour necrosis factor‐α via an L‐arginine‐dependent nitric oxide generating mechanism

[1]  M. Beggs,et al.  Interleukin‐1β inhibits glucokinase activity in clonal HIT‐T15 β‐cells , 1990 .

[2]  E. Jaffe,et al.  Macrophage and endothelial cell nitric oxide synthesis: cell-type selective inhibition by NG-aminoarginine, NG-nitroarginine and NG-methylarginine. , 1990, Biochemical and biophysical research communications.

[3]  G. Warnock,et al.  Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. , 1990, The Journal of clinical endocrinology and metabolism.

[4]  J. Drapier,et al.  IFN-gamma-activated macrophages: detection by electron paramagnetic resonance of complexes between L-arginine-derived nitric oxide and non-heme iron proteins. , 1990, Biochemical and biophysical research communications.

[5]  J. Nerup,et al.  Interaction of β-Cell Activity and IL-1 Concentration and Exposure Time in Isolated Rat Islets of Langerhans , 1989, Diabetes.

[6]  K. Bendtzen,et al.  Differential Sensitivity to β-Cell Secretagogues in Cultured Rat Pancreatic Islets Exposed to Human Interleukin-1β* , 1989 .

[7]  C. Nathan,et al.  Activated Murine Macrophages Secrete a Metabolite of Arginine with the Bioactivity of Endothelium-derived Relaxing Factor and the Chemical Reactivity of Nitric Oxide Materials and Methods , 2022 .

[8]  J. Hibbs,et al.  Nitric oxide: a cytotoxic activated macrophage effector molecule. , 1988, Biochemical and biophysical research communications.

[9]  M. Marletta,et al.  Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. , 1988, Biochemistry.

[10]  D. Eizirik.  Interleukin-1 induced impairment in pancreatic islet oxidative metabolism of glucose is potentiated by tumor necrosis factor. , 1988, Acta endocrinologica.

[11]  S. Lenzen,et al.  Structural requirements of alloxan and ninhydrin for glucokinase inhibition and of glucose for protection against inhibition , 1988, British journal of pharmacology.

[12]  J. Nerup,et al.  Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity. , 1987, Journal of immunology.

[13]  S. Sandler,et al.  Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. , 1987, Endocrinology.

[14]  M. Marletta,et al.  Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[15]  P. Comens,et al.  Interleukin 1 is Potent Modulator of Insulin Secretion from Isolated Rat Islets of Langerhans , 1987, Diabetes.

[16]  J. Hibbs,et al.  Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. , 1987, Science.

[17]  J. Hibbs,et al.  L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. , 1987, Journal of immunology.

[18]  S. Howell,et al.  Effect of Dynorphin on Insulin and Somatostatin Secretion, Calcium Uptake, and c-AMP Levels in Isolated Rat Islets of Langerhans , 1983, Diabetes.

[19]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[20]  K. Taylor,et al.  Effects of pregnancy in the rat on the size and insulin secretory response of the islets of Langerhans. , 1972, The Journal of endocrinology.

[21]  K. Taylor,et al.  Potassium ions and the secretion of insulin by islets of Langerhans incubated in vitro. , 1968, The Biochemical journal.

[22]  G. Gey,et al.  The Maintenance of Human Normal Cells and Tumor Cells in Continuous Culture: I. Preliminary Report: Cultivation of Mesoblastic Tumors and Normal Tissue and Notes on Methods of Cultivation , 1936 .